Disappearance of antibodies to SARS-associated coronavirus after recovery [18]

New England Journal of Medicine

Volumn 357, Issue 11, 2007, Pages 1162-1163

  Cao, Wu Chun ^a   Liu, Wei ^a   Zhang, Pan He ^a   Zhang, Fang ^a   Richardus, Jan H ^b  

^a BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; NEUTRALIZING ANTIBODY; VIRUS ANTIBODY;

ANTIBODY RESPONSE; ANTIBODY TITER; CONVALESCENCE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; LETTER; PRIORITY JOURNAL; SARS CORONAVIRUS; SEVERE ACUTE RESPIRATORY SYNDROME; BLOOD; FOLLOW UP; IMMUNOLOGY;

ANTIBODIES, VIRAL; FOLLOW-UP STUDIES; HUMANS; IMMUNOGLOBULIN G; SARS VIRUS; SEVERE ACUTE RESPIRATORY SYNDROME;

EID: 34548791207     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc070348     Document Type: Letter

References (5)

1. Liu W, Fontanet A, Zhang PH, et al. Two-year prospective study of the humoral immune response of patients with severe acute respiratory syndrome. J Infect Dis 2006;193:792-5.
2. Mo H, Zeng G, Ren X, et al. Longitudinal profile of antibodies against SARS-coronavirus in SARS patients and their clinical significance. Respirology 2006;11:49-53.
3. Yang ZY, Kong WP, Huang Y, et al. A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice. Nature 2004;428:561-4.
4. Subbarao K, McAuliffe J, Vogel L, et al. Prior infection and passive transfer of neutralizing antibody prevent replication of severe acute respiratory syndrome coronavirus in the respiratory tract of mice. J Virol 2004;78:3572-7.
5. Callow KA, Parry HF, Sergeant M, Tyrrell DA. The time course of the immune response to experimental coronavirus infection of man. Epidemiol Infect 1990;105:435-46.